Key Takeaways
- • ONTO Health, an AI-enabled fertility and longevity provider, closed a $20 million Series A financing round led by healthcare investors ARTIS and Humania on April 15, 2026.
- • The platform integrates evidence-based fertility care with AI-driven diagnostics, clinical automation, and longevity science to support clinical decision-making and patient outcomes.
- • Funding will expand ONTO Health's U.S. clinical operations and finance entry into the Gulf Cooperation Council (GCC) region, signaling geographic diversification of the fertility care market.
- • ONTO Health was founded by Dr. Roohi Jeelani, MD, FACOG, a double board-certified Reproductive Endocrinology and Infertility specialist serving as CEO and Co-Founder, anchoring the company's clinical credibility.
- • The company positions reproductive care within a broader lifelong health journey rather than as a narrowly focused service, reflecting market shift toward integrated women's health and longevity platforms.
Summary
ONTO Health, a Chicago-based AI-enabled fertility and longevity provider, has completed a $20 million Series A financing round backed by established healthcare investors ARTIS and Humania. The funding closes a significant capital raise for a company operating at the intersection of reproductive medicine and longevity science, two high-growth segments within digital health.
The ONTO Health platform differentiates itself through integration of evidence-based fertility protocols with proprietary AI-driven diagnostics and clinical automation tools. According to the company, the technology supports clinical decision-making by automating routine workflows and delivering advanced diagnostics to improve patient outcomes. This combination positions ONTO within the broader trend of AI adoption in clinical specialties where diagnostic precision and individualized treatment planning drive competitive advantage.
The company is led by Dr. Roohi Jeelani, MD, FACOG, a double board-certified specialist in Reproductive Endocrinology and Infertility who serves as CEO and Co-Founder. Dr. Jeelani's clinical background—recognized for leadership in fertility care and women's health innovation—provides operational credibility and clinical governance essential for a physician-led model in a regulated medical sector.
Capital deployment focuses on two strategic priorities: expansion of clinical operations within the United States and geographic entry into the Gulf Cooperation Council (GCC) region. The GCC expansion reflects growing private healthcare spending and demand for fertility services in the Middle East, offering an adjacent market for established U.S. digital health platforms seeking international growth.
ONTO Health's market positioning emphasizes reproductive care as part of a broader, lifelong health journey rather than as a narrowly focused fertility service. This conceptual shift aligns with emerging consumer preferences for integrated health platforms and reflects the company's dual focus on fertility and longevity—two segments attracting institutional capital in digital health and wellness sectors.
The ONTO Health platform differentiates itself through integration of evidence-based fertility protocols with proprietary AI-driven diagnostics and clinical automation tools. According to the company, the technology supports clinical decision-making by automating routine workflows and delivering advanced diagnostics to improve patient outcomes. This combination positions ONTO within the broader trend of AI adoption in clinical specialties where diagnostic precision and individualized treatment planning drive competitive advantage.
The company is led by Dr. Roohi Jeelani, MD, FACOG, a double board-certified specialist in Reproductive Endocrinology and Infertility who serves as CEO and Co-Founder. Dr. Jeelani's clinical background—recognized for leadership in fertility care and women's health innovation—provides operational credibility and clinical governance essential for a physician-led model in a regulated medical sector.
Capital deployment focuses on two strategic priorities: expansion of clinical operations within the United States and geographic entry into the Gulf Cooperation Council (GCC) region. The GCC expansion reflects growing private healthcare spending and demand for fertility services in the Middle East, offering an adjacent market for established U.S. digital health platforms seeking international growth.
ONTO Health's market positioning emphasizes reproductive care as part of a broader, lifelong health journey rather than as a narrowly focused fertility service. This conceptual shift aligns with emerging consumer preferences for integrated health platforms and reflects the company's dual focus on fertility and longevity—two segments attracting institutional capital in digital health and wellness sectors.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.